These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27902858)

  • 1. Reliable estimation of microvascular flow patterns in patients with disrupted blood-brain barrier using dynamic susceptibility contrast MRI.
    Hansen MB; Tietze A; Kalpathy-Cramer J; Gerstner ER; Batchelor TT; Østergaard L; Mouridsen K
    J Magn Reson Imaging; 2017 Aug; 46(2):537-549. PubMed ID: 27902858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
    Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
    J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of pseudoprogression in post-treatment glioblastoma using dynamic susceptibility contrast-derived oxygenation and microvascular transit time heterogeneity measures.
    Park JE; Kim HS; Kim N; Borra R; Mouridsen K; Hansen MB; Kim YH; Hong CK; Kim JH
    Eur Radiol; 2024 May; 34(5):3061-3073. PubMed ID: 37848773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain capillary transit time heterogeneity in healthy volunteers measured by dynamic contrast-enhanced T
    Larsson HBW; Vestergaard MB; Lindberg U; Iversen HK; Cramer SP
    J Magn Reson Imaging; 2017 Jun; 45(6):1809-1820. PubMed ID: 27731907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of postprocessing steps for residue function dependent dynamic susceptibility contrast (DSC)-MRI biomarkers and their clinical impact on glioma grading for both 1.5 and 3T.
    Bell LC; Stokes AM; Quarles CC
    J Magn Reson Imaging; 2020 Feb; 51(2):547-553. PubMed ID: 31206948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
    Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
    J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a T1 and T2* leakage correction method based on multiecho dynamic susceptibility contrast MRI using MION as a reference standard.
    Stokes AM; Semmineh N; Quarles CC
    Magn Reson Med; 2016 Aug; 76(2):613-25. PubMed ID: 26362714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced and amplified BOLD fluctuations in high-grade gliomas.
    Gupta L; Gupta RK; Postma AA; Sahoo P; Gupta PK; Patir R; Ahlawat S; Saha I; Backes WH
    J Magn Reson Imaging; 2018 Jun; 47(6):1616-1625. PubMed ID: 28963852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Leakage Correction for Single-Echo Dynamic Susceptibility Contrast Perfusion MRI Estimates of Relative Cerebral Blood Volume in High-Grade Gliomas by Accounting for Bidirectional Contrast Agent Exchange.
    Leu K; Boxerman JL; Cloughesy TF; Lai A; Nghiemphu PL; Liau LM; Pope WB; Ellingson BM
    AJNR Am J Neuroradiol; 2016 Aug; 37(8):1440-6. PubMed ID: 27079371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Different Post-Processing Algorithms for Dynamic Susceptibility Contrast Perfusion Imaging of Cerebral Gliomas.
    Kudo K; Uwano I; Hirai T; Murakami R; Nakamura H; Fujima N; Yamashita F; Goodwin J; Higuchi S; Sasaki M
    Magn Reson Med Sci; 2017 Apr; 16(2):129-136. PubMed ID: 27646457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of three leakage-correction methods for DSC-based measurement of relative cerebral blood volume with respect to heterogeneity in human gliomas.
    Kluge A; Lukas M; Toth V; Pyka T; Zimmer C; Preibisch C
    Magn Reson Imaging; 2016 May; 34(4):410-21. PubMed ID: 26708034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
    Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
    J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfusion MRI derived indices of microvascular shunting and flow control correlate with tumor grade and outcome in patients with cerebral glioma.
    Tietze A; Mouridsen K; Lassen-Ramshad Y; Østergaard L
    PLoS One; 2015; 10(4):e0123044. PubMed ID: 25875182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian modeling of Dynamic Contrast Enhanced MRI data in cerebral glioma patients improves the diagnostic quality of hemodynamic parameter maps.
    Tietze A; Nielsen A; Klærke Mikkelsen I; Bo Hansen M; Obel A; Østergaard L; Mouridsen K
    PLoS One; 2018; 13(9):e0202906. PubMed ID: 30256797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the Blood-Brain Barrier and Regional Perfusion in Tumor Development: MRI Insights from a Rat C6 Glioma Model.
    Huhndorf M; Moussavi A; Kramann N; Will O; Hattermann K; Stadelmann C; Jansen O; Boretius S
    PLoS One; 2016; 11(12):e0168174. PubMed ID: 28005983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast MRI with and without contrast agent leakage correction in paediatric brain tumours.
    Novak J; Withey SB; Lateef S; MacPherson L; Pinkey B; Peet AC
    Br J Radiol; 2019 Feb; 92(1094):20170872. PubMed ID: 30358415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T.
    Ingrisch M; Sourbron S; Morhard D; Ertl-Wagner B; Kümpfel T; Hohlfeld R; Reiser M; Glaser C
    Invest Radiol; 2012 Apr; 47(4):252-8. PubMed ID: 22373532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revealing hemodynamic heterogeneity of gliomas based on signal profile features of dynamic susceptibility contrast-enhanced MRI.
    Ji B; Wang S; Liu Z; Weinberg BD; Yang X; Liu T; Wang L; Mao H
    Neuroimage Clin; 2019; 23():101864. PubMed ID: 31176951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.